University Multiprofile Hospital for Active Treatment St. Ivan Rilski

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Myeloproliferative neoplasms

Running trials

• Active, not recruiting

  Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

  NCT04562389· Phase 3· Karyopharm Therapeutics Inc· Source